Sherilyn S. Dawn McCoy
Lead Independent DirectorMs. Sherilyn S. Dawn McCoy, M.B.A., M.S., also known as Sheri, is Vice Chairman of Galderma International S.A.S. She is Director of Sail Biomedicines, Inc. She was a Vice Chairman of Galderma Group AG until November 2026. She serves as Director at LARONDE, Inc. since November 2021. She served as the Chairman at Certara, Inc. since February 2018 until December 1, 2021 and served as Director since January 2018 until December 1, 2021. She has been Independent Director of Stryker Corporation since May 2, 2018 and serves as its Lead Independent Director since May 04, 2022. She also served as an Advisor at EQT Partners AB. She has been the Independent Chairperson of PAREXEL International Corporation since November 2021. She served as Chief Executive Officer of Avon Products, Inc. since April 23, 2012 until February 05, 2018. Since joining Avon Products in April 2012, she was responsible for driving new long-term growth initiatives and advancing Avon as the world's premier direct seller of quality beauty products. She has substantial general business leadership and innovation knowledge and experience as a senior leader of two global Fortune 500 companies. She served as Chairman of Aldevron and serves on the Board of Galderma. She served as Worldwide Chairman of Pharmaceuticals Group of Johnson & Johnson from January 1, 2009 to April 18, 2012 and also served as its Worldwide Chairman of Surgical Care from January 2008 to January 1, 2009. She served in various leadership roles with Johnson & Johnson since 1982 until 2012. She served as Division President of Consumer at Johnson & Johnson. She served as the Global President for the Baby and Wound Care franchise within Johnson & Johnson Consumer Companies, Inc. and also served as Group Chair in its Medical Devices & Diagnostics group since 2005. Ms. McCoy served as a Vice Chair at Johnson & Johnson. She began her career from Johnson & Johnson as an Associate Scientist in Research & Development for Personal Products Company and subsequently managed businesses in every major product sector, including consumer, prescription medicines and medical devices Ms. McCoy served as Group Chairman of Johnson & Johnson Company. She served as Director of Avon Products, Inc. since May 2012 until February 05, 2018. She has been an Independent Non-Executive Director of AstraZeneca PLC since October 1, 2017. She serves as a Director of The Partnership for New York City, Inc. She has worked in MedTech. She has been an Independent Director of Kimberly-Clark Corp., since September 12, 2018 and serves as its Lead Director since May 2024. She had been a Director of NovoCure Ltd since May 31, 2018 until June 08, 2022. She serves as a Director of Johnson & Johnson Company. Ms. McCoy has been a Director of United States Foundation for Inspiration and Recognition of Science and Technology since February 2007. Ms. McCoy serves on the boards of New Avon LLC; Catalyst; Stonehill College, Easton, Massachusetts, US; and FIRST. She holds four U.S. patents. She holds a Bachelor of Science degree in textile chemistry from the University of Massachusetts Dartmouth, an MS degree in chemical engineering from Princeton University and an MBA from Rutgers University, both in New Jersey, US. astra.
Positions
- Company NameKimberly-Clark CorporationStock CodeKMBPositionLead Independent DirectorColleagues
- MDMichael D. HsuChairman & CEO
- NUNelson UrdanetaSenior VP, CFO & Interim Principal Accounting Officer,
- JPJeffrey P. MelucciChief Strategy, Business Development & Administrative Officer
- FTFrancesco TintoChief Information & Global Business Services Officer
- CMChristopher M. JakubikInvestor Relations Contact
- CXClaudio Xavier Gonzalez LaporteChairman of Kimberly-Clark De Mexico S A De C V
- DADunia A. ShiveIndependent Director
- MTMark T. SmuckerIndependent Director
